Search

Author/Creator Meyrath, Max

1. Different contributions of chemokine N‐terminal features attest to a different ligand binding mode and a bias towards activation of ACKR3/CXCR7 compared with CXCR4 and CXCR3. (23rd March 2018)

Authors:
Szpakowska, Martyna; Nevins, Amanda M; Meyrath, Max; Rhainds, David; D'huys, Thomas; Guité‐Vinet, François; Dupuis, Nadine; Gauthier, Pierre‐Arnaud; Counson, Manuel; Kleist, Andrew; St‐Onge, Geneviève; Hanson, Julien; Schols, Dominique; Volkman, Brian F; Heveker, Nikolaus; Chevigné, Andy
Journal:
British journal of pharmacology
Issue:
Volume 175:Number 9(2018)
Page Start:
1419
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. The soluble form of pan-RTK inhibitor and tumor suppressor LRIG1 mediates downregulation of AXL through direct protein–protein interaction in glioblastoma. Issue 1 (6th September 2019)

Authors:
Neirinckx, Virginie; Hau, Ann-Christin; Schuster, Anne; Fritah, Sabrina; Tiemann, Katja; Klein, Eliane; Nazarov, Petr V; Matagne, André; Szpakowska, Martyna; Meyrath, Max; Chevigné, Andy; Schmidt, Mirko H H; Niclou, Simone P
Journal:
Neuro-oncology advances
Issue:
Volume 1:Issue 1(2019)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗